Joelien Jooste, Lesetja J. Legoabe, Kayhan Ilbeigi, Guy Caljon, Richard M. Beteck
{"title":"Hydrazinated geraniol derivatives as potential broad-spectrum antiprotozoal agents","authors":"Joelien Jooste, Lesetja J. Legoabe, Kayhan Ilbeigi, Guy Caljon, Richard M. Beteck","doi":"10.1002/ardp.202400430","DOIUrl":null,"url":null,"abstract":"<p>Geraniol, a primary component of several essential oils, has been associated with broad-spectrum antiprotozoal activities, although moderate to weak. This study primarily concentrated on the synthesis of hydrazinated geraniol derivatives as potential antiprotozoal agents. The synthesised compounds were tested in vitro against different parasitic protozoans of clinical relevance, including <i>Trypanosoma brucei brucei</i>, <i>Trypanosoma brucei rhodesiense</i>, <i>Trypanosoma cruzi</i> and <i>Leishmania infantum</i>. Compounds <b>6</b>, <b>8</b>, <b>13</b>, <b>14</b> and <b>15</b> demonstrated low micromolar activity against the different parasites. Compounds <b>8</b>, <b>13</b>, <b>14</b> and <b>15</b> had the highest efficacy against <i>Trypanosoma brucei rhodesiense</i>, as indicated by their respective IC<sub>50</sub> values of 0.74, 0.56, 1.26 and 1.00 µM. Compounds <b>6</b>, <b>14</b> and <b>15</b> displayed the best activity against <i>Trypanosoma brucei brucei</i>, with IC<sub>50</sub> values of 1.49, 1.48 and 1.85 µM, respectively. The activity of compounds <b>6</b>, <b>14</b> and <b>15</b> also extended to intracellular <i>Trypanosoma cruzi</i>, with IC<sub>50</sub> values of 5.14, 6.30 and 4.90 µM, respectively. Compound <b>6</b>, with an IC<sub>50</sub> value of 11.73 µM, and compound <b>14</b>, with an IC<sub>50</sub> value of 8.14 µM, demonstrated some modest antileishmanial activity.</p>","PeriodicalId":128,"journal":{"name":"Archiv der Pharmazie","volume":"357 10","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ardp.202400430","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archiv der Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ardp.202400430","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Geraniol, a primary component of several essential oils, has been associated with broad-spectrum antiprotozoal activities, although moderate to weak. This study primarily concentrated on the synthesis of hydrazinated geraniol derivatives as potential antiprotozoal agents. The synthesised compounds were tested in vitro against different parasitic protozoans of clinical relevance, including Trypanosoma brucei brucei, Trypanosoma brucei rhodesiense, Trypanosoma cruzi and Leishmania infantum. Compounds 6, 8, 13, 14 and 15 demonstrated low micromolar activity against the different parasites. Compounds 8, 13, 14 and 15 had the highest efficacy against Trypanosoma brucei rhodesiense, as indicated by their respective IC50 values of 0.74, 0.56, 1.26 and 1.00 µM. Compounds 6, 14 and 15 displayed the best activity against Trypanosoma brucei brucei, with IC50 values of 1.49, 1.48 and 1.85 µM, respectively. The activity of compounds 6, 14 and 15 also extended to intracellular Trypanosoma cruzi, with IC50 values of 5.14, 6.30 and 4.90 µM, respectively. Compound 6, with an IC50 value of 11.73 µM, and compound 14, with an IC50 value of 8.14 µM, demonstrated some modest antileishmanial activity.
期刊介绍:
Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.